QUEST DIAGNOSTICS INC
For the period ended Dec 31, 2023. Filed Feb 22, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 22, 2024
DGX$258.44-0.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive Income
| 2023 | 2022 | 2021 | |
|---|---|---|---|
| Net income | $908 | $1,015 | $2,080 |
| Other comprehensive income (loss): | |||
| Foreign currency translation adjustment | 5 | (8) | 13 |
| Net change in available-for-sale debt securities, net of taxes | — | — | (7) |
| Net deferred gains on cash flow hedges, net of taxes | 2 | 1 | 1 |
| Other comprehensive income (loss) | 7 | (7) | 7 |
| Comprehensive income | 915 | 1,008 | 2,087 |
| Less: Comprehensive income attributable to noncontrolling interests | 54 | 69 | 85 |
| Comprehensive income attributable to Quest Diagnostics | $861 | $939 | $2,002 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.